What caused the pre-market spike in 4591.T stock today?

The pre-market spike in 4591.T stock reflects heavy volume and technical buying. No company earnings were released before today. Traders moved the price on liquidity; confirm any company news or filings before sizing positions.

What is Meyka AI's forecast for 4591.T stock?

Meyka AI's forecast model projects a monthly target of **JPY 84.38** and a yearly target of **JPY 67.18** for 4591.T stock. These are model projections and not guarantees.

How healthy are Ribomic's fundamentals for 4591.T stock?

Ribomic shows strong cash per share (**JPY 60.06**) and book value (**JPY 60.49**). Earnings are negative with **EPS -23.85**, heavy R&D spending, and low revenue per share, so fundamentals are mixed.

Should I trade 4591.T stock on the volume spike?

Volume-driven moves can offer short-term opportunity but raise volatility risks. Use strict sizing and stop rules and watch for follow-through after the pre-market spike in 4591.T stock.

JP Stocks

Pre-market JPX: 4591.T stock Ribomic at JPY 99.00 on high volume 04 Mar 2026: what traders should watch

ByDanny Kontos March 4, 2026March 4, 2026

First trade shows 4591.T stock at JPY 99.00, up 15.12% in pre-market on JPX on 04 Mar 2026. Volume is unusually high at 48,506,700.00 shares versus an average of 990,452.00. This surge makes Ribomic Inc. one of Japan’s most active small-cap biotech names in early trading. We review the drivers, fundamentals, technicals and Meyka AI forecasts so traders can act with context.